Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Clinical trial NCT00003252 · COMPLETED

Trial details

NCT number: NCT00003252
Sponsor: Rush North Shore Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.